Mayne Pharma flags late evidence concerns in suit over $672M Cosette merger

Healthcare 2025-07-31 11:56 pm By Andy Sidler | Melbourne

Please login to bookmark

Mayne Pharma has said it may seek to shut out US drug maker Cosette’s expert evidence in proceedings over the purported termination of their $672 million merger.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au